These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 30576644)

  • 1. AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis.
    Ko CW; Singh S; Feuerstein JD; Falck-Ytter C; Falck-Ytter Y; Cross RK;
    Gastroenterology; 2019 Feb; 156(3):748-764. PubMed ID: 30576644
    [No Abstract]   [Full Text] [Related]  

  • 2. Mild-to-Moderate Ulcerative Colitis Guideline.
    Cross R; Ko CW; Singh S
    Gastroenterology; 2019 Feb; 156(3):768. PubMed ID: 30684447
    [No Abstract]   [Full Text] [Related]  

  • 3. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.
    Singh S; Feuerstein JD; Binion DG; Tremaine WJ
    Gastroenterology; 2019 Feb; 156(3):769-808.e29. PubMed ID: 30576642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild-to-Moderate Ulcerative Colitis (UC) Clinical Decision Support Tool.
    American Gastroenterological Association
    Gastroenterology; 2019 Feb; 156(3):765. PubMed ID: 30684448
    [No Abstract]   [Full Text] [Related]  

  • 5. Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial.
    Rubin DT; Cohen RD; Sandborn WJ; Lichtenstein GR; Axler J; Riddell RH; Zhu C; Barrett AC; Bortey E; Forbes WP
    J Crohns Colitis; 2017 Jul; 11(7):785-791. PubMed ID: 28333362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesalamine with MMX technology for the treatment of ulcerative colitis.
    Schreiber S; Kamm MA; Lichtenstein GR
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):299-314. PubMed ID: 19072380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesalamine in the treatment and maintenance of remission of ulcerative colitis.
    Ham M; Moss AC
    Expert Rev Clin Pharmacol; 2012 Mar; 5(2):113-23. PubMed ID: 22390554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACG Clinical Guideline: Ulcerative Colitis in Adults.
    Rubin DT; Ananthakrishnan AN; Siegel CA; Sauer BG; Long MD
    Am J Gastroenterol; 2019 Mar; 114(3):384-413. PubMed ID: 30840605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of extended MMX mesalamine therapy for acute, mild-to-moderate ulcerative colitis.
    Kamm MA; Lichtenstein GR; Sandborn WJ; Schreiber S; Lees K; Barrett K; Joseph R
    Inflamm Bowel Dis; 2009 Jan; 15(1):1-8. PubMed ID: 18671232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial: mesalazine in ulcerative colitis--is it time to revise treatment guidelines in the UK?
    Travis SP
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():1. PubMed ID: 16939422
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesalamine in the Initial Therapy of Ulcerative Colitis.
    Chibbar R; Moss AC
    Gastroenterol Clin North Am; 2020 Dec; 49(4):689-704. PubMed ID: 33121689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "One more time" 5-ASA retrial after a glucocorticosteroid induced remission in moderate to severe ulcerative colitis: a prospective community practice experience.
    Lipka S; Katz S; Kaur N
    J Crohns Colitis; 2013 May; 7(4):342-3. PubMed ID: 22871515
    [No Abstract]   [Full Text] [Related]  

  • 13. How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?
    Ardizzone S; Porro GB
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S238-9. PubMed ID: 18816705
    [No Abstract]   [Full Text] [Related]  

  • 14. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis.
    Olmstead J
    J Am Acad Nurse Pract; 2010 Nov; 22(11):586-92. PubMed ID: 21054632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of two different mesalamine formulations for the induction of remission in patients with ulcerative colitis: a double-blind, randomized study.
    Ito H; Iida M; Matsumoto T; Suzuki Y; Sasaki H; Yoshida T; Takano Y; Hibi T
    Inflamm Bowel Dis; 2010 Sep; 16(9):1567-74. PubMed ID: 20049950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
    Yamamoto T; Umegae S; Matsumoto K
    Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How important is mesalamine in the maintenance of steroid-refractory colitis?
    Actis GC; Marzano A; Pellicano R; Rizzetto M
    Inflamm Bowel Dis; 2008 Jul; 14(7):1026. PubMed ID: 18338772
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term maintenance treatment in ulcerative colitis: a 10-year follow-up.
    Bresci G; Parisi G; Bertoni M; Capria A
    Dig Liver Dis; 2002 Jun; 34(6):419-23. PubMed ID: 12132789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.